Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
This trial is testing a drug to see if multiple injections to the undereye bags of selected
patients decreases the volume of the eyebags as compared to placebo. Subjects will be
randomized to receive either one of two doses of POLAT-001 or placebo. POLAT-001 will be
injected into the eyebags at three of the visits. Each subject will attend 7-10 clinic visits
over 98 to 140 days total to assess efficacy and safety.